Showing results (361-370 of 456) with videos related to

Sort By:
Pageof 46
Journal of Medicinal Chemistry|December 11, 1975
Antimalarials. 10. Substituted 3-halo- and 3-methoxy-2-aryl-4-quinoline(di-n-butylaminomethyl)methanolsH R Munson, R E Johnson, J M Sanders, et al.
The American Journal on Addictions|July 11, 2001
Gradual dose taper following chronic buprenorphineA B Becker, E C Strain, G E Bigelow, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|September 16, 1998
Information about barriers to planned change: a randomized controlled trial involving continuing medical education lectures and commitment to changeP E Mazmanian, S R Daffron, R E Johnson, et al.
Annals of Internal Medicine|September 1, 1976
Adriamycin and enhanced radiation reaction in normal esophagus and skinF A Greco, H D Brereton, H Kent, et al.
Clinical Pharmacology and Therapeutics|August 15, 2008
Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomesS L Kacinko, H E Jones, R E Johnson, et al.
Nature|July 3, 1997
Detection of ozone on Saturn's satellites Rhea and DioneK S Noll, T L Roush, D P Cruikshank, et al.
Drug and Alcohol Dependence|May 24, 2000
Nalmefene: blockade of intravenous morphine challenge effects in opioid abusing humansH E Jones, R E Johnson, P J Fudala, et al.
Physical Review Letters|July 13, 2004
Energy loss by keV ions in siliconH O Funsten, S M Ritzau, R W Harper, et al.
American Journal of Public Health|April 1, 1989
Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic studyR A Hahn, L S Magder, S O Aral, et al.
DICP : the Annals of Pharmacotherapy|June 1, 1990
Acyclovir use and its surveillance in a general populationR E Johnson, J P Mullooly, B G Valanis, et al.
Pageof 46